Bozpah 62.5mg

Bozpah 62.5 mg is a medication primarily used to treat pulmonary arterial hypertension (PAH), a condition where there is high blood pressure in the arteries that supply blood to the lungs. The active ingredient in Bozpah is Bosentan, an endothelin receptor antagonist, which works by blocking the action of endothelin, a substance in the body that causes blood vessels to constrict. By relaxing and widening these blood vessels, Bozpah reduces blood pressure in the lungs, improving blood flow and reducing strain on the heart.

Bozpah helps alleviate symptoms of PAH, such as shortness of breath, fatigue, and dizziness and can improve the patient’s ability to exercise and their overall quality of life. It is typically taken orally, with dosage and duration prescribed by a healthcare professional based on the patient’s condition and response to treatment.

Patients taking Bozpah need regular monitoring of liver function and blood counts, as the medication can affect liver health and cause potential side effects. It’s important to follow the healthcare provider’s instructions and discuss any concerns or medication interactions before starting treatment with Bozpah.